La Jolla shares are trading higher after Innoviva entered into a definitive agreement to acquire the company for $5.95 per share and an incremental $0.28 per share for additional cash proceeds, or an implied enterprise value of approximately $149 million.
$LJPC
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
La Jolla shares are trading higher after Innoviva entered into a definitive agreement to acquire the company for $5.95 per share and an incremental $0.28 per share for additional cash proceeds, or an implied enterprise value of approximately $149 million.